Lozach outlines how the Corticosteroid Stewardship Alliance plans to bring clinician data and adverse event costs to payers and lawmakers.
Killian Lozach, MBA
Advertisement
Killian Lozach, MBA, business development and alliance management lead, Woodberry Associates.
Articles by Killian Lozach, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Weekly Insulin Efsitora Alfa (Onswik) Gains FDA approval for Type 2 Diabetes
2
Nearly 9 in 10 US Adults With CKD Don't Know They Have It, With Pranav Garimella
3
Diabetes Dialogue: Weekly Insulin Efsitora Alfa Gets FDA Approval for Type 2 Diabetes
4
Anti-Alpha-Gal Antibodies Block IgE Binding in Alpha-Gal Syndrome
5